You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 2, February 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology, Other
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Invited Critique

Gerald W. Peskin, MD
Oakland, Calif

Arch Surg. 2001;136:215.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Like many other reports in the literature of the 1990s, this study of 77 patients with carcinoma of the extrahepatic bile ducts expresses the opinion that an aggressive surgical approach to these lesions can result in a higher percentage of long-term survivors with modest perioperative morbidity and mortality.

By "aggressive in approach," one implies adequate preoperative assessment using computed tomography scans, duplex ultrasonography, endoscopic retrograde cholangiopancreatography or magnetic resonance cholangiopancreatography, and angiography as needed to establish a staging system that will refine the operative intervention of those individuals who can undergo curative resection. Furthermore, for those lesions involving the confluence of the hepatic ducts, the real decision area of cholangiocarcinoma, aggressiveness means the ability and willingness to resect segments of the liver (the caudate lobe in particular) to achieve negative margins and a reasonable long-term survival. While the Rochester group's series confirms 1990s results, only 2 . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.